AgingResearch.NewsJoin free

Medication safety review

Medication safety review has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Aug 30, 2022: “Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans”.

Exposure

1 paper studies it2 findingsUpdated

See all 1 papers on medication safety review

At a glance

The findings reach people, from one lab or study. 1 lab in 2 countries.

“The viMSR cohort (N = 602) outperformed the FTE cohort (N = 7052) in total Medicare costs ($2162/y lower; P = 0.020)”
Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older AmericansJournal of the American Pharmacists Association : JAPhA2022doi:10.1016/j.japh.2022.08.022

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 2 countries
  • Funders: Norsk Fysioterapeutforbund and 2 more
  • 2 of 2 findings with company ties
  • Humans1

What is medication safety review linked with?

2

Studies link medication safety review with 2 measures, most often mortality (1 study) and Total Medicare costs (1).

Mortality

downin humans1

1 study

  1. Medication safety review is associated with mortality in humans (3.8% fewer died in 2019; P < 0.001).

    “Implementing pharmacists' recommendations in MSRs was associated with improved health care resource utilization and mortality for MSR-eligible beneficiaries.”

    HumansMSR-eligible Medicare Part D beneficiaries; compared with beneficiaries who failed to engageImplementation of ≥1 recommendation2019

    Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans

    Journal of the American Pharmacists Association : JAPhA

Total Medicare costs

downin humans1

1 study

  1. Medication safety review is associated with total Medicare costs in humans ($2162/y lower; P = 0.020).

    “The viMSR cohort (N = 602) outperformed the FTE cohort (N = 7052) in total Medicare costs ($2162/y lower; P = 0.020)”

    HumansMSR-eligible Medicare Part D beneficiaries; compared with beneficiaries who failed to engageImplementation of ≥1 recommendation2018–2019

    Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans

    Journal of the American Pharmacists Association : JAPhA

Latest

Related